Abstract
To compare two coverage-based planning (CP) techniques with fixed margin-based (FM) planning for high-risk prostate cancer treatments, with the exclusive consideration of the dosimetric impact of delineation uncertainties of target structures and normal tissues. In this work, 19-patient data sets were involved. To estimate structure dose for each delineated contour under the influence of interobserver contour variability and CT image quality limitations, 1000 alternative structures were simulated by an average-surface-of-standard-deviation model, which utilized the patient-specific information of delineated structure and CT image contrast. An IMRT plan with zero planning-target-volume (PTV) margin on the delineated prostate and seminal vesicles [clinical-target-volume (CTV prostate) and CTVSV] was created and dose degradation due to contour variability was quantified by the dosimetric consequences of 1000 alternative structures. When D98 failed to achieve a 95% coverage probability objective D98,95 ≥ 78 Gy (CTV prostate) or D98,95 ≥ 66 Gy (CTVSV), replanning was performed using three planning techniques: (1) FM (PTV prostate margin = 4,5,6 mm and PTVSV margin = 4,5,7 mm for RL, PA, and SI directions, respectively), (2) CPOM whi...Continue Reading
References
Jul 29, 1998·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·C FiorinoR Calandrino
Sep 25, 1998·International Journal of Radiation Oncology, Biology, Physics·S M ZhouM S Anscher
Feb 16, 1999·International Journal of Radiation Oncology, Biology, Physics·C RaschJ V Lebesque
Aug 6, 1999·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J C StroomB J Heijmen
Aug 7, 1999·Medical Physics·P RemeijerM van Herk
Jun 23, 2000·International Journal of Radiation Oncology, Biology, Physics·M van HerkJ V Lebesque
Aug 15, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alan McKenzieBen Mijnheer
Jan 24, 2003·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Elisabeth Weiss, Clemens F Hess
Jan 31, 2004·Seminars in Radiation Oncology·Marcel van Herk
Jan 5, 2005·International Journal of Radiation Oncology, Biology, Physics·Kirsten E I DeurlooMarcel van Herk
Aug 15, 2006·International Journal of Radiation Oncology, Biology, Physics·Joep C Stroom, Ben J M Heijmen
Feb 7, 2007·Medical Physics·J J GordonJ V Siebers
Sep 11, 2007·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Zhanrong GaoLee Gerig
Apr 4, 2008·Medical Physics·J J Gordon, J V Siebers
Sep 16, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Primoz PetricRichard Pötter
Sep 25, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dominique P HuyskensEmile Salamon
Apr 3, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hilke VorwerkHans Christiansen
Apr 22, 2009·Medical Physics·J J Gordon, J V Siebers
Nov 7, 2009·Journal of Medical Physics·C F Njeh
Jan 22, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Johannes G KorporaalUulke A van der Heide
Mar 17, 2010·Medical Physics·J J GordonJ V Siebers
Mar 17, 2010·Medical Physics·Jian WuJeffrey Williamson
Jun 15, 2010·International Journal of Radiation Oncology, Biology, Physics·Elisabeth WeissJeffrey Williamson
Apr 2, 2011·Medical Physics·Huijun XuJeffrey V Siebers
May 26, 2012·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Yick Wing HoHui Geng
Dec 4, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Manju SharmaJeffrey V Siebers
Feb 28, 2013·Physics in Medicine and Biology·Xuejun GuSteve B Jiang
Apr 6, 2013·Medical Physics·Christopher F NjehColin G Orton
Oct 6, 2014·Medical Physics·Huijun XuJeffrey V Siebers